Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
暂无分享，去创建一个
E. Winer | N. Robert | R. Carlson | H. Rugo | R. Finn | M. Danso | J. O’Shaughnessy | B. Hellerstedt | D. Yardley | E. Charpentier | K. Miller | L. Schwartzberg | M. Saleh | J. Specht | M. Neubauer | P. Richards | I. García-Ribas | Eric Charpentier | M. Saleh | I. Garcia-Ribas